A new study by researchers at Case Western Reserve University School of Medicine reveals that a chemical used in the diabetes drug Ozempic and the weight-management drug Wegovy is not associated with an increased risk for suicidal thoughts. The findings about the chemical—known as semaglutide—is particularly significant because this summer the European Medicines Agency (EMA) launched an investigation of its potential dangers. Semaglutide is a chemical of the glucagon-like peptide receptor (GLP1R) that helps regulate blood sugar in type 2 … Continue reading New study concludes diabetes and weight-loss drugs—Ozempic and Wegovy—not associated with increased risk for suicidal thoughts